LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
1-Year Return
25.93%
This Quarter Return
-6.61%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.27B
AUM Growth
-$291M
(-19%)
Cap. Flow
-$128M
Cap. Flow
% of AUM
-10.05%
Top 10 Holdings %
Top 10 Hldgs %
24.84%
Holding
415
New
40
Increased
54
Reduced
57
Closed
258
Top Buys
| 1 |
CVS Health
CVS
|
$33M |
| 2 |
Incyte
INCY
|
$26.4M |
| 3 |
Bristol-Myers Squibb
BMY
|
$24.7M |
| 4 |
Halozyme
HALO
|
$24.5M |
| 5 |
Equity Lifestyle Properties
ELS
|
$22.9M |
Top Sells
| 1 |
Pultegroup
PHM
|
$28.6M |
| 2 |
Biogen
BIIB
|
$24.6M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$24.1M |
| 4 |
Abbott
ABT
|
$15.5M |
| 5 |
Pool Corp
POOL
|
$14.2M |
Sector Composition
| 1 | Healthcare | 56.62% |
| 2 | Financials | 13.8% |
| 3 | Consumer Discretionary | 12.01% |
| 4 | Technology | 6.24% |
| 5 | Energy | 3.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Exelon
EXC
$43.9B
| – | – |
-13,208
| Closed | -$544K |
|
202
Expeditors International
EXPD
$16.4B
| – | – |
-4,358
| Closed | -$585K |
|
203
Expedia Group
EXPE
$26.6B
| – | – |
-1,787
| Closed | -$323K |
|
204
FedEx
FDX
$53.7B
| – | – |
-1,651
| Closed | -$427K |
|
205
FirstEnergy
FE
$25.1B
| – | – |
-8,500
| Closed | -$354K |
|
206
Fiserv
FI
$73.4B
| – | – |
-3,908
| Closed | -$406K |
|
207
Fifth Third Bancorp
FITB
$30.2B
| – | – |
-5,714
| Closed | -$249K |
|
208
Intuit
INTU
$188B
| – | – |
-2,504
| Closed | -$1.61M |
|
209
Intuitive Surgical
ISRG
$167B
| – | – |
-1,770
| Closed | -$636K |
|
210
Illinois Tool Works
ITW
$77.6B
| – | – |
-2,460
| Closed | -$607K |
|
211
JB Hunt Transport Services
JBHT
$13.9B
| – | – |
-2,163
| Closed | -$442K |
|
212
Johnson Controls International
JCI
$69.5B
| – | – |
-9,738
| Closed | -$792K |
|
213
Kellanova
K
$27.8B
| – | – |
-10,723
| Closed | -$649K |
|
214
KLA
KLAC
$119B
| – | – |
-926
| Closed | -$398K |
|
215
Kimberly-Clark
KMB
$43.1B
| – | – |
-2,349
| Closed | -$336K |
|
216
Kroger
KR
$44.8B
| – | – |
-13,865
| Closed | -$628K |
|
217
Korro Bio
KRRO
$312M
| – | – |
-14,141
| Closed | -$3.63M |
|
218
Liberty Global Class A
LBTYA
$4.05B
| – | – |
-8,007
| Closed | -$224K |
|
219
L3Harris
LHX
$51B
| – | – |
-1,849
| Closed | -$394K |
|
220
Linde
LIN
$220B
| – | – |
-4,651
| Closed | -$1.61M |
|
221
Eli Lilly
LLY
$652B
| – | – |
-4,546
| Closed | -$1.26M |
|
222
Lockheed Martin
LMT
$108B
| – | – |
-1,114
| Closed | -$396K |
|
223
MetLife
MET
$52.9B
| – | – |
-10,801
| Closed | -$675K |
|
224
Magna International
MGA
$12.9B
| – | – |
-2,211
| Closed | -$226K |
|
225
Moderna
MRNA
$9.78B
| – | – |
-1,809
| Closed | -$459K |
|